Miguel Afonso Filipe

Publications by Year

Research Areas

Biosimilars and Bioanalytical Methods, Pharmaceutical studies and practices, Intracranial Aneurysms: Treatment and Complications, Monoclonal and Polyclonal Antibodies Research, Traumatic Brain Injury and Neurovascular Disturbances

Most-Cited Works

• → The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis(2017)181 cited
• → Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque‐type psoriasis: 30‐week results from the phase 3, confirmatory EGALITY study(2017)74 cited
• → GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes(2016)33 cited
• → Giant posterior fossa meningioma: the importance of early diagnosis and challenges concerning treatment(2019)10 cited
• → THU0145 Pharmacokinetics and Safety of GP2015, A Proposed Etanercept Biosimilar, and Etanercept Originator Product in Healthy Male Subjects: A Randomised Two-Way Crossover Study(2016)7 cited
• → Giant Post-Traumatic Frontoethmoid Osteoma: Diagnostic, Therapeutic and Reconstructive Approach(2020)6 cited
• → State‐of‐the‐art immunogenicity evaluation in phase 3 confirmatory study (EGALITY) with etanercept biosimilar GP2015(2017)5 cited
• → Emergency surgery for brainstem cavernoma haemorrhage with severe neurological presentation. Is it indicated and worthwhile?(2020)5 cited
• → THU0144 Pharmacokinetics and Safety of GP2015, A Proposed Etanercept Biosimilar, Administered Subcutaneously by An Autoinjector or Prefilled Syringe in Healthy Male Subjects(2016)3 cited
• → Predictive factors for ventriculoperitoneal shunt placement in aneurysmatic subarachnoid hemorrhages(2024)3 cited